Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Horizon Therapeutics Public Limited Company (HZNP : NSDQ)

• Company Description    Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland. Number of Employees: 1,890

• Price / Volume Information    Yesterday's Closing Price: $90.35 Daily Weekly Monthly 20 Day Moving Average: 2,245,871 shares Shares Outstanding: 229.88 (millions) Market Capitalization: $20,770.02 (millions) Beta: 1.11 52 Week High: $120.48 52 Week Low: $82.51 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -18.23% -7.91% 12 Week -2.66% 7.00% Year To Date -16.16% 1.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 70 St. Stephen's Green - Dublin 2,L2 D02 E2X4 IRL ph: 011-353-1772-2100 fax: 224-383-3001 investor-relations@horizontherapeutics.com http://www.horizontherapeutics.com

• General Corporate Information    Officers Timothy P. Walbert - President; Chief Executive Officer and Chairman of Paul W. Hoelscher - Executive Vice President and Chief Financial Offic Miles W. McHugh - Senior Vice President and Chief Accounting Officer Michael Grey - Director William F. Daniel - Director Peer Information Horizon Therapeutics Public Limited Company (CORR.) Horizon Therapeutics Public Limited Company (RSPI) Horizon Therapeutics Public Limited Company (CGXP) Horizon Therapeutics Public Limited Company (BGEN) Horizon Therapeutics Public Limited Company (GTBP) Horizon Therapeutics Public Limited Company (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G46188101 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 229.88 Most Recent Split Date: (:1) Beta: 1.11 Market Capitalization: $20,770.02 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $1.36 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $5.59 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 12.73% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: 16.17 Trailing 12 Months: 14.76 PEG Ratio: 1.27 Price Ratios Price/Book: 4.31 Price/Cash Flow: 14.03 Price / Sales: 5.51 EPS Growth vs. Year Ago Period: 4,366.67% vs. Previous Quarter: -4.96% Sales Growth vs. Year Ago Period: 158.54% vs. Previous Quarter: -12.74% ROE 03/31/22 - 32.08 12/31/21 - 26.66 09/30/21 - 26.85 ROA 03/31/22 - 16.88 12/31/21 - 13.64 09/30/21 - 14.33 Current Ratio 03/31/22 - 3.57 12/31/21 - 3.16 09/30/21 - 2.83 Quick Ratio 03/31/22 - 3.30 12/31/21 - 2.90 09/30/21 - 2.55 Operating Margin 03/31/22 - 38.33 12/31/21 - 35.23 09/30/21 - 37.23 Net Margin 03/31/22 - 22.87 12/31/21 - 16.57 09/30/21 - 18.66 Pre-Tax Margin 03/31/22 - 21.40 12/31/21 - 14.35 09/30/21 - 16.28 Book Value 03/31/22 - 20.96 12/31/21 - 20.60 09/30/21 - 19.62 Inventory Turnover 03/31/22 - 3.83 12/31/21 - 3.31 09/30/21 - 3.53 Debt-to-Equity 03/31/22 - 0.53 12/31/21 - 0.55 09/30/21 - 0.57 Debt-to-Capital 03/31/22 - 34.63 12/31/21 - 35.35 09/30/21 - 36.50

Powered by Zacks Investment Research ©